about
Recognition and treatment of psoriasis. Special considerations in elderly patients.Assessment of T regulatory cells and expanded profiling of autoantibodies may offer novel biomarkers for the clinical management of systemic sclerosis and undifferentiated connective tissue disease.Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha.Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases.CD4 Lymphocyte enumeration: comparison between flow cytometry and enzyme immunoassay.Prevalence of human papilloma virus type 5 DNA in lesional and non-lesional skin scales of Italian plaque-type psoriatic patients: association with disease severity.Paraneoplastic Raynaud phenomenon with digital necrosis associated with hyperhomocysteinemia and antiphospholipid antibodies.Endothelin-1 levels are increased in sera and lesional skin extracts of psoriatic patients and correlate with disease severity.Acute pancreatitis as initial manifestation of systemic lupus erythematosus and subacute cutaneous lupus erythematosus: report of two casesNail Involvement in Pemphigus VulgarisEffective Therapy with Anti-TNF- in Patients with Psoriatic Arthritis Is Associated with Decreased Levels of Metalloproteinases and Angiogenic Cytokines in the Sera and Skin LesionsCytokine profiles during infliximab monotherapy in psoriatic arthritisInfluence of skin area, age and sex on corneometric determinationsRaynaud's phenomenon secondary to weever fish stingsSoluble E-selectin and soluble tumour necrosis factor receptor (60 kD) serum levels in patients with psoriasisCorrelation of lesional skin corneometry values with serum E-selectin levels and disease severity in patients affected by plaque-type psoriasis: recovery after effective therapysICAM-1, sIL-2R and beta 2-microglobulin serum levels in patients affected with psoriasis: relationship with disease severityIncreased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasisInterleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8IL-5 levels in the serum and blister fluid of patients with bullous pemphigoid: correlations with eosinophil cationic protein, RANTES, IgE and disease severityIncreased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activityDecreased interleukin-7 and transforming growth factor-beta1 levels in blister fluids as compared to the respective serum levels in patients with bullous pemphigoid. Opposite behavior of TNF-alpha, interleukin-4 and interleukin-10Lupus mastitis: a 2-year history of a single localization of lupus erythematosus mimicking breast carcinomaA case of erythema elevatum diutinum associated with antiphospholipid antibodies
P50
Q34746727-F0B3491C-F036-4EAC-9A53-D7964364C153Q36925590-7D55BFFE-EDDF-428B-AD27-006CB07966F0Q38582187-BFC2EE41-E7CD-41B2-B4E3-DD86302B3FFDQ42670957-208E809A-61A7-4596-BE08-4270D114DE60Q43453865-EF65DE1D-3BC0-4FB3-9050-2BCA9ED0B373Q45525059-8C52AEBE-F3C0-4680-83E3-AA2A921EAB28Q48560928-2BFBD096-1332-4E3D-B608-C922CCDA1A5BQ50903380-B951AE30-DCC8-40A1-B109-E372D062878DQ58899727-E5ED9BCD-5DC1-4EA7-95E3-FEC8F2662DF9Q58899737-A875351B-C42B-4282-B221-6F181C1BBF1AQ59154938-ECDF88AA-3F7A-40E7-AB5C-3CF2DDA02A36Q59154943-5E74B833-5AC6-4A2F-A5BB-A18765AB81F8Q59154953-D07123F6-26A7-4789-89F7-8E327CFD8D4DQ71182989-0BDE891F-6CBC-4A5D-BF0B-65D111FAD9F8Q71690029-903CA7BE-1F90-4946-9AAC-B46DDCB03D1BQ71745300-FF084E50-C770-4F23-ADBD-11DB553813E8Q72401373-6DD6BC50-EA91-4DB6-9FBC-B854682FE456Q73162637-2BFF8C13-9887-48E6-8842-0B3E2CE8EA3BQ73567562-C2867F81-5E1E-47EA-9FA1-82910BC9C0D7Q74382094-31E79C27-2829-44AB-8D21-895147E55057Q77208194-8982FED8-C227-4D6C-B2EA-B7CF250FCE65Q77363716-79890C8A-47FF-4D7C-8ABD-87C495F7891CQ81487472-64514436-0BAD-4289-B014-B131E38D59C1Q94325524-DD43876A-2D63-4DF5-831B-0CB0C6C1CAB8
P50
description
Forscher
@de
chercheur
@fr
hulumtuese
@sq
investigador
@es
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Anna Mussi
@ast
Anna Mussi
@en
Anna Mussi
@es
Anna Mussi
@nl
type
label
Anna Mussi
@ast
Anna Mussi
@en
Anna Mussi
@es
Anna Mussi
@nl
prefLabel
Anna Mussi
@ast
Anna Mussi
@en
Anna Mussi
@es
Anna Mussi
@nl
P1153
7006645287
P21
P31
P496
0000-0002-1756-8319